Gemigliptin (tartrate hydrate), CAS [[1375415-82-9]]

Produktübersicht

• Artikelname: Gemigliptin (tartrate hydrate), CAS [[1375415-82-9]]
• Artikelnummer: MCE-HY-14892B
• Hersteller Artikelnummer: HY-14892B
• Alternativnummer: MCE-HY-14892B-25MG,MCE-HY-14892B-10MG,MCE-HY-14892B-100MG,MCE-HY-14892B-50MG,MCE-HY-14892B-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: LC15-0444 (tartrate hydrate)

Produktbeschreibung

Gemigliptin (LC15-0444 ) tartrate hydrate is a selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate hydrate exhibits potent anti-glycation properties. Gemigliptin tartrate hydrate can be used for the research of advanced glycation end products (AGE)-related diabetic complications[1][2].

Produkteigenschaften

• Molekulargewicht: 666.49
• Reinheit: 99.83
• CAS Nummer: [1375415-82-9]
• Formel: C18H19F8N5O2.C4H6O6.3/2H2O
• Target-Kategorie: Dipeptidyl Peptidase

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound